Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Universal Screening for G6PD Deficiency Detects More Cases Than Selective Testing

Ilan Segal, MD, Shraga Aviner, MD PhD, Ashraf Abu Rmaileh, MD, Ornit Cohen, Msc, Avraham Sayag, MD, Shmuel Zangen, MD

Blood (2016) 128 (22): 1261.

https://doi.org/10.1182/blood.V128.22.1261.1261

Published: 2016

Journal Articles

Frequency and Natural History of Inherited Bone Marrow Failure Syndromes: The Israeli Inherited Bone Marrow Failure Registry

Hannah Tamary, MD, Daniella Nishri, MD, Joanne Yacobovich, MD, Rama Zilber, RN, Shraga Aviner, MD, PhD, Polina Stepensky, MD, Shoshana S Vilk- Ravel, Menachem Bitan, Chaim Kaplinsky, MD, Ayelet Ben Barak, MD, Joseph Kapelusnik, MD, Ariel Koren, MD, Carina Levin, MD, Isaac Yaniv, MD, Philip S Rosenberg, PhD, Blanche P. Alter, MD

Blood (2008) 112 (11): 1045.

https://doi.org/10.1182/blood.V112.11.1045.1045

Published: 2008

Journal Articles

Mycoplasma Pneumonia Infection - a Possible unrecognized Cause for Immune Thrombocytopenic Purpura

Shraga Aviner, MD, PhD, Daniel London, MD, Shulamith Horowitz, PhD, Menachem Schlesinger, MD, Gilles Lugassy, MD

Blood (2008) 112 (11): 4555.

https://doi.org/10.1182/blood.V112.11.4555.4555

Published: 2008

Journal Articles

Spontaneous Resolution of Extreme Essential Thrombocytosis in a Child

Shraga Aviner, MD, PhD, Menachem Schlesinger, MD, Gilles Lugassy, MD

Blood (2008) 112 (11): 4563.

https://doi.org/10.1182/blood.V112.11.4563.4563

Published: 2008

Journal Articles

Eradication of B Cell Malignancies by Anti-3 rd Party CTLs: A Novel Role for MHC Class I.

Assaf Lask, MSc, Polina Goichberg, PhD, Rinat Goren-Arbel, PhD, Oren Milstein, MSc, Shraga Aviner, MD, Ilan Feine, Tirza Klein, PhD, Alain Berrebi, MD, Yair Reisner, PhD

Blood (2007) 110 (11): 2759.

https://doi.org/10.1182/blood.V110.11.2759.2759

Published: 2007

Journal Articles

Eradication of B-Lymphoma by Allogeneic Anti-Third Party Host Non-Reactive CTLs: Growing Evidence for TCR Independent Reactivity Against B-Cell Malignancies.

Shraga Aviner, MD, Fabian D. Arditti, PhD, Rinat Arbel-Goren, PhD, Tirza Klein, PhD, Yair Reisner, PhD

Blood (2004) 104 (11): 3055.

https://doi.org/10.1182/blood.V104.11.3055.3055

Published: 2004

NARROW

Universal Screening for G6PD Deficiency Detects More Cases Than Selective Testing

Frequency and Natural History of Inherited Bone Marrow Failure Syndromes: The Israeli Inherited Bone Marrow Failure Registry

Mycoplasma Pneumonia Infection - a Possible unrecognized Cause for Immune Thrombocytopenic Purpura

Spontaneous Resolution of Extreme Essential Thrombocytosis in a Child

Eradication of B Cell Malignancies by Anti-3 rd Party CTLs: A Novel Role for MHC Class I.

Eradication of B-Lymphoma by Allogeneic Anti-Third Party Host Non-Reactive CTLs: Growing Evidence for TCR Independent Reactivity Against B-Cell Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Universal Screening for G6PD Deficiency Detects More Cases Than Selective Testing

Frequency and Natural History of Inherited Bone Marrow Failure Syndromes: The Israeli Inherited Bone Marrow Failure Registry

Mycoplasma Pneumonia Infection - a Possible unrecognized Cause for Immune Thrombocytopenic Purpura

Spontaneous Resolution of Extreme Essential Thrombocytosis in a Child

Eradication of B Cell Malignancies by Anti-3 rd Party CTLs: A Novel Role for MHC Class I.

Eradication of B-Lymphoma by Allogeneic Anti-Third Party Host Non-Reactive CTLs: Growing Evidence for TCR Independent Reactivity Against B-Cell Malignancies.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only